| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Scanlan Sean F. | Chief Innovation Officer | C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA | /s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan | 23 Jan 2026 | 0001856371 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMCI | Common Stock | Options Exercise | $38,520 | +53,500 | +14% | $0.7200 | 427,099 | 21 Jan 2026 | Direct | F1 |
| transaction | TMCI | Common Stock | Award | $0 | +262,500 | +61% | $0.000000 | 689,599 | 22 Jan 2026 | Direct | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMCI | Stock Option (Right to Buy) | Options Exercise | $0 | +53,500 | $0.000000 | 0 | 21 Jan 2026 | Common Stock | 53,500 | $0.7200 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Includes 283,948 restricted stock units. |
| F2 | Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date. |
| F3 | Includes 511,291 restricted stock units |
| F4 | The stock option vested in equal annual installments over 4 years, commencing on January 26, 2016 with the last installment vesting on January 26, 2020. |